Who’s tracking the risks from peptides? In many cases, no oneAn NBC News investigation of how states monitor problems linked to peptides revealed a patchwork of oversight policies. Experts say allowing compounding pharmacies to make certain peptides still won’t provide the oversight that’s needed.Mr. Ilkin / Getty Images fileAug. 27, 2026, 12:13 PM EDTAfter Sarah Moran took a dose of a popular peptide in February, she said, her heart began racing when she stood up, and she experienced dizziness that lasted for days.Just a moment.We are getting your experience ready.